The Pharma Data
MAY 2, 2023
Bonello has more than 30 years of financial leadership experience, including 15 years in the clinical research industry. a clinical trial data collection company, since 2021. From 2008 to 2021, Mr. Bonello held roles of increasing responsibility at Nasdaq-listed PRA Health Sciences, Inc.,
Quanticate
OCTOBER 16, 2020
By the end of 2007, and towards the beginning of 2008, the Clinical Data Interchange Standards Consortium (CDISC) gained ground in its mission to develop a global set of standards. Gathering all the heterogenous data and mapping to the internal standards of the pharma companies proved to be the greatest challenge of the time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Vial
FEBRUARY 23, 2024
In 2022, the global market value of patient portals within the clinical research and healthcare industries was estimated to be US $2.9 In 2008, prior to ARRA and the HITECH Act, only 10% of hospitals in the United States had transitioned from paper-based methods into EMRs, primarily due to their exorbitant set-up costs.
Drug Target Review
SEPTEMBER 26, 2023
She completed a PhD at Durham University which focused on investigating the mechanisms of cardiotoxicity of cancer therapies using clinically relevant in vitro human models of cardiac physiology paired with novel methodologies to evaluate structural and functional toxicities. 2008 Mar;153 Suppl 2(Suppl 2):S1-209. cited 2023 Jun 15].
NIH Director's Blog: Drug Development
OCTOBER 11, 2022
For clinical researchers, click chemistry has emerged as a workhorse in drug discovery and the improved targeting of cancer chemotherapies and other small-molecule drugs. Science 2008, 320 (5876), 664–667. [6] The approach also is being used to improve delivery of antibody-based therapies and to create new biomaterials.
The Pharma Data
DECEMBER 17, 2020
Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital. She joined VMS BioMarketing in 2008 and has served as its president and CEO since 2011.
The Pharma Data
NOVEMBER 5, 2020
Prior to joining Navitor, Hughes served as president and CSO of Zafgen and previously led Zafgen as CEO from 2008 to 2017. State University, will have overall responsibility for the scientific and clinical strategy, including scientific and clinical affairs. Hughes, CEO of Navitor Pharmaceuticals, to the board of directors.
Expert insights. Personalized for you.
40 
Let's personalize your content